EUCTR2017-005170-19-FI进行中（未招募）1 期
A Long-Term Follow-up Safety Study for Patients with Idiopathic Parkinson’s Disease (PD) Implanted with the DDS and/or Who Received Treatment in the Main Study and/or Extension Study - Long-Term Follow-up Safety After DDS Implantation with/without CDNF Infusions
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Patients who completed Visit 4, implantation of the DDS, in the main study (HP-CD-CL-2002).
- •2. Patients that fulfil any of the following criteria:
- •a. Discontinued the main study (HP-CD-CL-2002) after Visit 4, or, the extension study (HP-CD-CL-2003), or,
- •b. Completed the main study (HP-CD-CL-2002) having received 6 doses of treatment, but did not continue in the extension study (HP-CD-CL-2003), or,
- •c. Patients that completed also the extension study, receiving a total of 12 doses of treatment (HP-CD-CL-2003).
- •3. Provision of informed consent. The patient is judged by the investigator to be alert and oriented to person, place, time and situation when giving the informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 10
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 10
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A Long-Term Follow-up Safety Study for Patients with Parkinson’s Disease (PD) Implanted with the Drug Delivery System (DDS) and/or Who Received Treatment in the Main Study and/or Extension StudyIdiopathic Parkinson's DiseaseMedDRA version: 21.1Level: LLTClassification code 10013113Term: Disease Parkinson'sSystem Organ Class: 100000004852EUCTR2017-005170-19-SERenishaw Neuro Solutions Ltd.15
进行中（未招募）
1 期
A follow-on study in patients who have received gene therapy for Beta-thalassemia in the TIGET-BTHAL study to assess safety and effectiveness of treatment.Beta-thalassemiaMedDRA version: 20.1Level: LLTClassification code 10054660Term: Thalassemia betaSystem Organ Class: 100000004850EUCTR2017-001366-14-ITGLAXOSMITHKLINE RESEARCH AND DEVELOPMENT10
已完成
不适用
A clinical study for evaluating safety of long-term consumption -Non-blind, safety verification study taking 1 times dose of test food "KW-01" in healthy adults.Healthy adultsJPRN-UMIN000025376Kowa Company, Ltd.10
已完成
3 期
ong Term Follow-up Study of SI-613 in Patients with OAOsteoarthritisJPRN-jRCT2080223799SEIKAGAKU CORPORATIO160
进行中（未招募）
不适用
A Phase III, Safety Extension Study in Patients withErythropoietic Protoporphyria (EPP) - Phase III EPP Safety Extension StudyEUCTR2009-011018-51-GBClinuvel Pharmaceuticals Limited15